Trial intelligence / Profile preview

Propranolol for Opioid Induced Hyperalgesia in Laparoscopic Surgery

NCT02934763Phase 4Unknown

Sponsor
Pontificia Universidad Católica de Chile
Start
Oct 2016
Primary completion
Apr 2017
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of propranolol in opioid-induced hyperalgesia (OIH) (3 arms), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Postoperative opioid use in the post anesthesic care unit. Status: unknown.

02

Drugs

propranolol
03

Conditions

opioid-induced hyperalgesia (OIH)

Beyond the preview

Go deeper on NCT02934763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02934763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call